The price of targeted drugs, which is a very heartbreaking problem for Chinese people, is very expensive. In the absence of national price reduction and negotiation for price reduction, the price of targeted drugs should be measured in tens of thousands. The price per month or per course of treatment is about 20,000 yuan or more, about 20-50,000 yuan. Recently, the state negotiated 17 varieties of targeted drugs into the clinic, the price of drugs will drop significantly. In addition, they will enter into social security and give the people a good reimbursement ratio. When patients really do targeted drug therapy, the monthly consumption is about 1-2,000 yuan, at most no more than 2-3,000 yuan, and its price will come down. No matter how high the price of a drug is, the main thing to look at is whether it is suitable for the patient, because now the price is not a big problem, but more to look at the indications, whether it has this indication, the patient with it is not suitable, the drug is suitable may be more important.